GPAT 2022 Candidate Answers
GPAT 2022 Candidate Answers
Print ResponseSheet
Question ID:- 28
Options:-
.Mu–opioid , Option ID :- 109,
. Delta–opioid , Option ID :- 110,
. Kappa–opioid , Option ID :- 111,
. NOP , Option ID :- 112,
Answer Given:- Kappa–opioid , Option ID : -111
Question ID:- 22
Options:-
. , Option ID :- 85,
. , Option ID :- 86,
. , Option ID :- 87,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 1 of 48
Response Sheet 02/05/22, 8:48 PM
. , Option ID :- 88,
Question ID:- 10
glycogen.
liver.
Choose the most appropriate answer from the options given below:
Options:-
.Both Statement I and Statement II are correct , Option ID :- 37,
. Both Statement I and Statement II are incorrect , Option ID :- 38,
. Statement I is correct but Statement II is incorrect , Option ID :- 39,
. Statement I is incorrect but Statement II is correct , Option ID :- 40,
Answer Given:- Both Statement I and Statement II are correct , Option
ID : -37
Question ID:- 11
Options:-
.Invertin , Option ID :- 41,
. Myrosin , Option ID :- 42,
. Emulsin , Option ID :- 43,
. Zymase , Option ID :- 44,
Answer Given:- Myrosin , Option ID : -42
Question ID:- 12
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 2 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.N-Butyl bromide , Option ID :- 45,
. Isobutyl bromide , Option ID :- 46,
. sec-Butyl bromide , Option ID :- 47,
. ter-Butyl bromide , Option ID :- 48,
Answer Given:- Isobutyl bromide , Option ID : -46
Question ID:- 32
List I List II
B. 0.1M Sodium
II. Potassium bromate
thiosulphate
D. 0.1M Perchloric
IV. Arsenic trioxide
acid
V. Potassium hydrogen
phthalate
Options:-
.A - IV, B - II, C - III, D - V , Option ID :- 125,
. A - IV, B - II, C - III, D - I , Option ID :- 126,
. A - I, B - IV, C - II, D - III , Option ID :- 127,
. A - III, B - II, C - IV, D - I , Option ID :- 128,
Answer Given:- A - IV, B - II, C - III, D - I , Option ID : -126
Question ID:- 26
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 3 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Secondary substitution undergoes slow elimination and fast
substitution , Option ID :- 101,
. Primary substitution undergoes slow elimination and fast substitution ,
Option ID :- 102,
. Tertiary substitution undergoes slow elimination and fast substitution ,
Option ID :- 103,
. Primary substitution does not undergo elimination and substitution
reactions , Option ID :- 104,
Answer Given:- Secondary substitution undergoes slow elimination and
fast substitution , Option ID : -101
Question ID:- 33
Options:-
.E = (bE10 + aE20)/(a+b) , Option ID :- 129,
. E = E0 + (0.0592/n) X log Q , Option ID :- 130,
. E = E0 + (0.0592/n) X log (Red/Ox) , Option ID :- 131,
. E = E10 + E20/2 , Option ID :- 132,
Answer Given:- E = E0 + (0.0592/n) X log (Red/Ox) , Option ID : -131
Question ID:- 2
Options:-
.Depression of freezing-point , Option ID :- 5,
. Elevation of boiling-point , Option ID :- 6,
. Lowering of vapour pressure , Option ID :- 7,
. Osmotic pressure , Option ID :- 8,
Answer Given:- Lowering of vapour pressure , Option ID : -7
Question ID:- 21
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 4 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Zn(Hg), HCl , Option ID :- 81,
. NaBH4, CH3OH , Option ID :- 82,
. NH2NH2, NaOH , Option ID :- 83,
. SnCl2, CH3OH , Option ID :- 84,
Answer Given:- SnCl2, CH3OH , Option ID : -84
Question ID:- 20
Options:-
. , Option ID :- 77,
. , Option ID :- 78,
. , Option ID :- 79,
. , Option ID :- 80,
Question ID:- 6
Heme is ________ .
Options:-
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 5 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 15
Options:-
.(-) Threose , Option ID :- 57,
. (+) Threose , Option ID :- 58,
. (-) Erythrose , Option ID :- 59,
. (+) Erythrose , Option ID :- 60,
Answer Given:- (-) Threose , Option ID : -57
Question ID:- 34
Options:-
.30 , Option ID :- 133,
. 15 , Option ID :- 134,
. 6 , Option ID :- 135,
. 0 , Option ID :- 136,
Answer Given:- 0 , Option ID : -136
Question ID:- 8
Citric acid cycle is the final pathway during the oxidation of _______ .
Options:-
.Carbohydrates , Option ID :- 29,
. Lipids , Option ID :- 30,
. Proteins , Option ID :- 31,
. All of these , Option ID :- 32,
Answer Given:- All of these , Option ID : -32
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 6 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 13
Identify the functional groups from the below mentioned options that lead to weakening of benzoic
acid:
A. –OH
B. –Cl
C. –NH2
D. –NO2
Options:-
.A and B , Option ID :- 49,
. A and C , Option ID :- 50,
. B and C , Option ID :- 51,
. A and D , Option ID :- 52,
Answer Given:- B and C , Option ID : -51
Question ID:- 38
Options:-
.Triplet and doublet , Option ID :- 149,
. Quartet and doublet , Option ID :- 150,
. Triplet and quartet , Option ID :- 151,
. Triplet and triplet , Option ID :- 152,
Answer Given:- Quartet and doublet , Option ID : -150
Question ID:- 30
Options:-
.Z-epoxide , Option ID :- 117,
. Meso epoxide , Option ID :- 118,
. E-epoxide , Option ID :- 119,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 7 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 24
Identify the major product formed in the above reaction from the four
choices listed below:
Options:-
.(S)-(+)-2-methylbutanoic acid , Option ID :- 93,
. (S)-(-)-2-methylbutanoic acid , Option ID :- 94,
. (S)-(+)-2-methylbutanol , Option ID :- 95,
. (S)-(-)-2-methylbutanol , Option ID :- 96,
Answer Given:- (S)-(-)-2-methylbutanoic acid , Option ID : -94
Question ID:- 16
Options:-
.Baeyer Villiger oxidation , Option ID :- 61,
. Sharpless epoxidation , Option ID :- 62,
. Prevost oxidation , Option ID :- 63,
. Lossen rearrangement , Option ID :- 64,
Answer Given:- Baeyer Villiger oxidation , Option ID : -61
Question ID:- 18
Among the following organic compounds, the one that is non-aromatic is:
Options:-
. , Option ID :- 69,
. , Option ID :- 70,
. , Option ID :- 71,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 8 of 48
Response Sheet 02/05/22, 8:48 PM
. , Option ID :- 72,
Question ID:- 1
Match the symbols in the List I with the terms used in the List II of
conductance measurements, and
List I List II
Symbols Terms
II. Electrical
B. Λ
conductance
IV. Equivalent
D. ρ
conductance
Options:-
.A - III, B - I, C - IV, D - II , Option ID :- 1,
. A - II, B - IV, C - I, D - III , Option ID :- 2,
. A - IV, B - II, C - III, D - I , Option ID :- 3,
. A - I, B - III, C - II, D - IV , Option ID :- 4,
Answer Given:- A - III, B - I, C - IV, D - II , Option ID : -1
Question ID:- 35
A. Volatile substances
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?U…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 9 of 48
Response Sheet 02/05/22, 8:48 PM
B. Insoluble substances
reagent
Options:-
.A only , Option ID :- 137,
. A and C , Option ID :- 138,
. A, B and D , Option ID :- 139,
. A, B, C and D , Option ID :- 140,
Answer Given:- A only , Option ID : -137
Question ID:- 9
Options:-
.Sphingomyelin , Option ID :- 33,
. Lysolecithin , Option ID :- 34,
. Cardiolipin , Option ID :- 35,
. Galactosylceramide , Option ID :- 36,
Answer Given:- Galactosylceramide , Option ID : -36
Question ID:- 4
Boric acid with molecular weight 61.83 was partitioned between water
and amyl alcohol at 25 °C. The amount of boric acid was determined to
be 0.24 g in 250 ml of amyl alcohol and 0.32 g in 100 ml water. The
partition coefficient of boric acid between water and amyl alcohol, when
calculated at molar concentration for each of the solution, is:
Options:-
.1.33 , Option ID :- 13,
. 0.75 , Option ID :- 14,
. 0.30 , Option ID :- 15,
. 3.33 , Option ID :- 16,
Answer Given:- 3.33 , Option ID : -16
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 10 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 5
Drugs ‘A’, ‘B’ and ‘C’ follow zero order, first order and second order
degradation kinetics, respectively, but have the same rate constant.
Which of the following statement is true in this respect:
Options:-
.Drug ‘A’ will be the first to degrade by 50% , Option ID :- 17,
. Drug ‘B’ will be the first to degrade by 50% , Option ID :- 18,
. Drug ‘C’ will be the first to degrade by 50% , Option ID :- 19,
. Drugs ‘B’ and ‘C’ will degrade by 50% at the same time , Option ID :-
20,
Answer Given:- Drug ‘B’ will be the first to degrade by 50% , Option ID :
-18
Question ID:- 29
Options:-
.High reactivity and low selectivity , Option ID :- 113,
. Low reactivity and high selectivity , Option ID :- 114,
. High reactivity and high selectivity , Option ID :- 115,
. Low reactivity and low selectivity , Option ID :- 116,
Answer Given:- High reactivity and high selectivity , Option ID : -115
Question ID:- 19
Options:-
. , Option ID :- 73,
. , Option ID :- 74,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 11 of 48
Response Sheet 02/05/22, 8:48 PM
. , Option ID :- 75,
. , Option ID :- 76,
Question ID:- 23
Options:-
.5β, 6!!-dibromocholestane , Option ID :- 89,
. 2β, 3! -dibromocholestane , Option ID :- 90,
. 5α, 6β-dibromocholestane , Option ID :- 91,
. 5α, 6β-dibromo 3β-hydroxy cholestane , Option ID :- 92,
Answer Given:- 5α, 6β-dibromo 3β-hydroxy cholestane , Option ID : -92
Question ID:- 17
Options:-
.Mannich reaction , Option ID :- 65,
. Robinson annulation , Option ID :- 66,
. Stork reaction , Option ID :- 67,
. Bamford Stevens reaction , Option ID :- 68,
Answer Given:- Stork reaction , Option ID : -67
Question ID:- 3
Match the statements in List I with their correct answers in List II,
respectively, in respect to modified 1st law of thermodynamics, and
List I List II
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 12 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.A - II, B - I, C - III, D - IV , Option ID :- 9,
. A - I, B - III, C - II, D - IV , Option ID :- 10,
. A - III, B - I, C - II, D - IV , Option ID :- 11,
. A - IV, B - I, C - II, D - III , Option ID :- 12,
Answer Given:- A - I, B - III, C - II, D - IV , Option ID : -10
Question ID:- 27
Options:-
.Norephedrine , Option ID :- 105,
. Pseudoephedrine , Option ID :- 106,
. Ephedrine , Option ID :- 107,
. Norpseudoephedrine , Option ID :- 108,
Answer Given:- Norpseudoephedrine , Option ID : -108
Question ID:- 37
Options:-
.Sodium carbonate , Option ID :- 145,
. Sodium chloride , Option ID :- 146,
. Sodium hydrogen carbonate , Option ID :- 147,
. Sodium metabisulfite , Option ID :- 148,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 13 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 36
Options:-
. , Option ID :- 141,
. , Option ID :- 142,
. , Option ID :- 143,
. , Option ID :- 144,
Question ID:- 31
Options:-
.8.3 , Option ID :- 121,
. 7.0 , Option ID :- 122,
. 3.8 , Option ID :- 123,
. 8.7 , Option ID :- 124,
Answer Given:- 8.3 , Option ID : -121
Question ID:- 25
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 14 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Trifluroethyl alcohol; methanol; formic acid; acetic acid , Option ID :-
97,
. Formic acid; acetic acid; methanol; trifluroethyl alcohol , Option ID :-
98,
. Methanol; formic acid; acetic acid; trifluroethyl alcohol , Option ID :-
99,
. Methanol; acetic acid; formic acid; trifluoroethyl alcohol , Option ID :-
100,
Answer Given:- Methanol; acetic acid; formic acid; trifluoroethyl alcohol ,
Option ID : -100
Question ID:- 7
Options:-
.lowering activation energy barrier (ΔGf) for a reaction , Option ID :- 25,
. denaturing the substate , Option ID :- 26,
. increasing the temperature , Option ID :- 27,
. changing the pH , Option ID :- 28,
Answer Given:- lowering activation energy barrier (ΔGf) for a reaction ,
Option ID : -25
Question ID:- 14
Options:-
.4-Bromophenol , Option ID :- 53,
. 2-Bromophenol , Option ID :- 54,
. 2,4-Dibromophenol , Option ID :- 55,
. 2,4,6-Triibromophenol , Option ID :- 56,
Answer Given:- 2-Bromophenol , Option ID : -54
Subject : Pharmaceutics SET 02
Question ID:- 51
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 15 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Plasticizer , Option ID :- 201,
. Stabilizers , Option ID :- 202,
. Surface treatment film , Option ID :- 203,
. Slip agent , Option ID :- 204,
Answer Given:- Plasticizer , Option ID : -201
Question ID:- 53
Which one of the following manufacturing facility may not be required for
oral solid dosage
form?
Options:-
.Material Handling , Option ID :- 209,
. Chemical weighing , Option ID :- 210,
. Blending , Option ID :- 211,
. Aspectic filling , Option ID :- 212,
Answer Given:- Blending , Option ID : -211
Question ID:- 70
Options:-
.Cost of ingredients only , Option ID :- 277,
. Cost of professional fee only , Option ID :- 278,
. Cost of ingredients and cost of dispensing only , Option ID :- 279,
. Cost of ingredients and professional fee only , Option ID :- 280,
Answer Given:- Cost of ingredients and professional fee only , Option ID :
-280
Question ID:- 58
Which one of the following statement holds true for Passive Diffusion?
Options:-
.Greater the area and greater the thickness, faster is the diffusion ,
Option ID :- 229,
. Rate of drug transfer is directly proportional to the concentration
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 16 of 48
Response Sheet 02/05/22, 8:48 PM
. Rate of transfer of ionised drug species is 3-4 times the rate for
unionised drug species , Option ID :- 231,
. Greater the membrane/water partition coefficient of drug, slower is
the absorption , Option ID :- 232,
Answer Given:- Greater the membrane/water partition coefficient of
drug, slower is the absorption , Option ID : -232
Question ID:- 71
Options:-
.Composition , Option ID :- 281,
. Indication , Option ID :- 282,
. Pricing , Option ID :- 283,
. Dosage and administration , Option ID :- 284,
Answer Given:- Composition , Option ID : -281
Question ID:- 73
Options:-
.A, B and D only , Option ID :- 289,
. A only , Option ID :- 290,
. A and D only , Option ID :- 291,
. A, C and D only , Option ID :- 292,
Answer Given:- A, B and D only , Option ID : -289
Question ID:- 66
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 17 of 48
Response Sheet 02/05/22, 8:48 PM
List I List II
Buffers pH Value
Options:-
.A -II , B -III , C -IV , D -I , Option ID :- 261,
. A -III , B -II , C -IV , D -I , Option ID :- 262,
. A -II , B -IV , C -I , D -II , Option ID :- 263,
. A -III , B -IV , C -II , D -I , Option ID :- 264,
Answer Given:- A -III , B -II , C -IV , D -I , Option ID : -262
Question ID:- 49
Given below are two statements, one is labelled as Assertion A and the
other is labelled as
Reason R
some tablet.
In light of the above statements, choose the correct answer from the
options given below
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 18 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Both A and R are true and R is the correct explanation of A , Option ID
:- 193,
. Both A and R are true but R is NOT the correct explanation of A ,
Option ID :- 194,
. A is true but R is false , Option ID :- 195,
. A is false but R is true , Option ID :- 196,
Answer Given:- Both A and R are true and R is the correct explanation of
A , Option ID : -193
Question ID:- 56
dissolution rate, may happen due to which one of the following reasons?
Options:-
.Addition of cyclodextrin , Option ID :- 221,
. Addition of surfactant to increase the surface tension , Option ID :-
222,
. Addition of hydrophilic diluent , Option ID :- 223,
. Surface charges due to extreme particle size reduction , Option ID :-
224,
Answer Given:- Surface charges due to extreme particle size reduction ,
Option ID : -224
Question ID:- 46
Options:-
.Community pharmacy , Option ID :- 181,
. Government service , Option ID :- 182,
. Health-systems pharmacy , Option ID :- 183,
. Organizational management , Option ID :- 184,
Answer Given:- Community pharmacy , Option ID : -181
Question ID:- 69
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 19 of 48
Response Sheet 02/05/22, 8:48 PM
powdered opium
A. Powdered grass
D. Powdered digitalis
Options:-
.A and D only , Option ID :- 273,
. B and D only , Option ID :- 274,
. B and C only , Option ID :- 275,
. A and C only , Option ID :- 276,
Answer Given:- B and D only , Option ID : -274
Question ID:- 65
Options:-
.Critical micellar concentration , Option ID :- 257,
. Kraft point , Option ID :- 258,
. Cloud point , Option ID :- 259,
. Solubilization , Option ID :- 260,
Answer Given:- Kraft point , Option ID : -258
Question ID:- 68
pharmaceutical powders?
Options:-
.Coulter counter , Option ID :- 269,
. Andrerson apparatus , Option ID :- 270,
. Quantasorb , Option ID :- 271,
. Optical microscopy , Option ID :- 272,
Answer Given:- Coulter counter , Option ID : -269
Question ID:- 43
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 20 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.
A and B only , Option ID :- 169,
Question ID:- 72
Options:-
.Reducing agents often cause fading of dyes , Option ID :- 285,
. Anionic dyes are the most stable at acid pHs , Option ID :- 286,
. Basic dyes are not sensitive to alkalies , Option ID :- 287,
. Cationic dyes may be precipitated by soaps and clays , Option ID :-
288,
Answer Given:- Reducing agents often cause fading of dyes , Option ID :
-285
Question ID:- 64
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 21 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Give diffraction bands , Option ID :- 253,
. Characteristics geometrical shapes , Option ID :- 254,
. Sharp melting point , Option ID :- 255,
. All of these , Option ID :- 256,
Answer Given:- All of these , Option ID : -256
Question ID:- 44
Given below are two statements, one is labelled as Assertion A and the
other is labelled as
Reason R
propellant is lost.
In light of the above statements, choose the correct answer from the
options given below
Options:-
.Both A and R are true and R is the correct explanation of A , Option ID
:- 173,
. Both A and R are true but R is NOT the correct explanation of A ,
Option ID :- 174,
. A is true but R is false , Option ID :- 175,
. A is false but R is true , Option ID :- 176,
Answer Given:- Both A and R are true and R is the correct explanation of
A , Option ID : -173
Question ID:- 39
Options:-
.PVC , Option ID :- 153,
Question ID:- 61
conjugating agent?
Options:-
.Glucouronidation , Option ID :- 241,
. Sulfation , Option ID :- 242,
. Methylation , Option ID :- 243,
. Glutathione conjugation , Option ID :- 244,
Answer Given:- Sulfation , Option ID : -242
Question ID:- 40
Options:-
.Purified Water , Option ID :- 157,
. Water for Injection USP , Option ID :- 158,
. Sterile Water for Injection USP , Option ID :- 159,
. Bacteriostatic Water for Injection USP , Option ID :- 160,
Answer Given:- Bacteriostatic Water for Injection USP , Option ID : -160
Question ID:- 76
List I List II
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 23 of 48
Response Sheet 02/05/22, 8:48 PM
V. Mycobacterium identification
Options:-
.A -III , B -V , C -II, D -I , Option ID :- 301,
. A -II , B -IV , C -I , D -III , Option ID :- 302,
. A -IV , B -II , C -III , D -I , Option ID :- 303,
. A -I , B -III , C -II , D -IV , Option ID :- 304,
Answer Given:- A -II , B -IV , C -I , D -III , Option ID : -302
Question ID:- 59
Options:-
.15 litres , Option ID :- 233,
. 20 litres , Option ID :- 234,
. 27 litres , Option ID :- 235,
. 35 litres , Option ID :- 236,
Answer Given:- 15 litres , Option ID : -233
Question ID:- 75
List I List II
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 24 of 48
Response Sheet 02/05/22, 8:48 PM
V. E.coli
Options:-
.A -III , B -IV , C -I , D - V , Option ID :- 297,
. A IV, B -I , C -II , D - III , Option ID :- 298,
. A -III , B - I, C -IV , D -II , Option ID :- 299,
. A -I , B -IV , C -II , D -III , Option ID :- 300,
Answer Given:- A -I , B -IV , C -II , D -III , Option ID : -300
Question ID:- 74
Options:-
.A, B and C only , Option ID :- 293,
. B, C and D only , Option ID :- 294,
. A and B only , Option ID :- 295,
. C and D only , Option ID :- 296,
Answer Given:- A, B and C only , Option ID : -293
Question ID:- 48
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 25 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Seal Coating , Option ID :- 189,
. Subcoating , Option ID :- 190,
. Syrup Coating , Option ID :- 191,
. Polishing , Option ID :- 192,
Answer Given:- Seal Coating , Option ID : -189
Question ID:- 50
Options:-
.Both Statement I and Statement II are correct , Option ID :- 197,
. Both Statement I and Statement II are incorrect , Option ID :- 198,
.
Statement I is correct but Statement II is incorrect , Option ID :-
199,
Question ID:- 47
Given below are two statements, one is labelled as Assertion A and the
other is labelled as
Reason R
necessary.
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 26 of 48
Response Sheet 02/05/22, 8:48 PM
removed.
In light of the above statements, choose the correct answer from the
options given below
Options:-
.Both A and R are true and R is the correct explanation of A , Option ID
:- 185,
. Both A and R are true and R is the correct explanation of A , Option ID
:- 186,
. A is true but R is false , Option ID :- 187,
. A is false but R is true , Option ID :- 188,
Answer Given:- Both A and R are true and R is the correct explanation of
A , Option ID : -185
Question ID:- 67
Options:-
.A and B only , Option ID :- 265,
. A, B and C only , Option ID :- 266,
. A, B and D only , Option ID :- 267,
. A and D only , Option ID :- 268,
Answer Given:- A, B and D only , Option ID : -267
Question ID:- 45
Options:-
.Digestion , Option ID :- 177,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 27 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 54
Options:-
.Bolting , Option ID :- 213,
. Mixing , Option ID :- 214,
. Tumbling , Option ID :- 215,
. Grinding , Option ID :- 216,
Answer Given:- Mixing , Option ID : -214
Question ID:- 42
Options:-
.Freeze dryer , Option ID :- 165,
. Fluid bed dryer , Option ID :- 166,
. Spray dryer , Option ID :- 167,
. Flash dryer , Option ID :- 168,
Answer Given:- Fluid bed dryer , Option ID : -166
Question ID:- 63
Options:-
.The acetate buffer , Option ID :- 249,
. The lysis buffer , Option ID :- 250,
. The potassium citrate , Option ID :- 251,
. The carbonic acid , Option ID :- 252,
Answer Given:- The lysis buffer , Option ID : -250
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 28 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 60
List I List II
A. When two dosage forms have equal I. When their total body
tmax clearance is constant.
Options:-
.A - II, B -I , C -IV- , D - III , Option ID :- 237,
. A -I , B -II , C -III , D -IV , Option ID :- 238,
. A -I, B -IV, C -III, D -II , Option ID :- 239,
. A -III , B -I , C -II , D -IV , Option ID :- 240,
Answer Given:- A -I , B -II , C -III , D -IV , Option ID : -238
Question ID:- 62
Options:-
.Channel-Lattice type , Option ID :- 245,
. Quinhydrone complex , Option ID :- 246,
. Layer type , Option ID :- 247,
. Clathrates , Option ID :- 248,
Answer Given:- Clathrates , Option ID : -248
Question ID:- 55
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 29 of 48
Response Sheet 02/05/22, 8:48 PM
Which of the following is NOT a cause for the drug undergoing nonlinear
pharmacokinetics
Options:-
.Enzyme inhibition , Option ID :- 217,
. Enzyme induction , Option ID :- 218,
. Saturation of carrier molecules , Option ID :- 219,
. Saturation of plasma protein binding , Option ID :- 220,
Answer Given:- Enzyme induction , Option ID : -218
Question ID:- 52
Options:-
.k = [2.303/ t(a − b)] x [log a(a − x) / b(b − x) ] , Option ID :- 205,
. k = [2.303/ t(a − b)] x [log b(a − x) / a(b − x) ] , Option ID :- 206,
. k = [2.303/ t(a − b)] / [log b(a − x) / a(b − x) ] , Option ID :- 207,
. k = [2.303/ t(a − b)] / [log a(a − x) / b(b − x) ] , Option ID :- 208,
Answer Given:- k = [2.303/ t(a − b)] / [log a(a − x) / b(b − x) ] ,
Option ID : -208
Question ID:- 57
processes of absorption?
Options:-
.Passive diffusion , Option ID :- 225,
. Active transport , Option ID :- 226,
. Ion - pair transport , Option ID :- 227,
. Pinocytosis , Option ID :- 228,
Answer Given:- Passive diffusion , Option ID : -225
Question ID:- 41
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 30 of 48
Response Sheet 02/05/22, 8:48 PM
glycerin, water,
Options:-
.Cold cream , Option ID :- 161,
. Vanishing cream , Option ID :- 162,
. Foundation cream , Option ID :- 163,
. All purpose cream , Option ID :- 164,
Answer Given:- All purpose cream , Option ID : -164
Subject : Pharmacognosy SET 02
Question ID:- 78
Options:-
.Tyrosine , Option ID :- 309,
. Tryptophan , Option ID :- 310,
. Ornithine , Option ID :- 311,
. Methidine , Option ID :- 312,
Answer Given:- Tyrosine , Option ID : -309
Question ID:- 86
Options:-
.Diosgenin + 3 Glucose , Option ID :- 341,
. Diosgenin + 3 Rhamnose , Option ID :- 342,
. Diosgenin + 2 Glucose + 1 Rhamnose , Option ID :- 343,
. Diosgenin + 1 Glucose + 2 Rhamnose , Option ID :- 344,
Answer Given:- Diosgenin + 2 Glucose + 1 Rhamnose , Option ID : -343
Question ID:- 83
A. Rutin is a Bioflavonoid.
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 31 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.A and B only , Option ID :- 329,
. A, B and C only , Option ID :- 330,
. A, B and D only , Option ID :- 331,
. All of these , Option ID :- 332,
Answer Given:- A, B and C only , Option ID : -330
Question ID:- 85
Options:-
.Hydrodistillation method , Option ID :- 337,
. Extraction method , Option ID :- 338,
. Enfleurage method , Option ID :- 339,
. Hand press method , Option ID :- 340,
Answer Given:- Hydrodistillation method , Option ID : -337
Question ID:- 77
B. Authentication of extracts
C. Detection of pesticides
Options:-
.A, B and D only , Option ID :- 305,
. D only , Option ID :- 306,
. A and D only , Option ID :- 307,
. A, B, C and D , Option ID :- 308,
Answer Given:- A, B, C and D , Option ID : -308
Question ID:- 82
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 32 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Higher Iodine value as compared to the standards , Option ID :- 325,
. Higher Acid value as compared to the standards , Option ID :- 326,
. Higher Peroxide value as compared to the standards , Option ID :- 327,
. Higher level of Unsaponifiable matter , Option ID :- 328,
Answer Given:- Higher Acid value as compared to the standards , Option
ID : -326
Question ID:- 79
Options:-
.Pyrolidine & piperidine , Option ID :- 313,
. Pyrolidine & pyridine , Option ID :- 314,
. Pyrolidine & oscine , Option ID :- 315,
. Piperidine & oscine , Option ID :- 316,
Answer Given:- Pyrolidine & pyridine , Option ID : -314
Question ID:- 81
Options:-
.Determination of volatile oil , Option ID :- 321,
. Determination of refractive index , Option ID :- 322,
. Detection of alkaloids , Option ID :- 323,
. Determination of vascular bundles , Option ID :- 324,
Answer Given:- Determination of refractive index , Option ID : -322
Question ID:- 80
Options:-
.Tropane alkaloids , Option ID :- 317,
. Steroidal glycoalkaloids , Option ID :- 318,
. Amino alkaloids , Option ID :- 319,
. Quinoline alkaloids , Option ID :- 320,
Answer Given:- Quinoline alkaloids , Option ID : -320
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 33 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 84
Options:-
.Lignified cells , Option ID :- 333,
. Pericyclic fibres , Option ID :- 334,
. Concentric vascular bundles , Option ID :- 335,
. Crystals of calcium oxalate , Option ID :- 336,
Answer Given:- Lignified cells , Option ID : -333
Question ID:- 92
List I List II
(Poisoning) (Treatment)
1. Warfarin P. Pralidoxime
2. Carbon
Q. Oxygen
monoxide
3. Cyanide R. Vitamin K
S. Dicobalt
4. Nitrites
edatate
5. T. Methylene
Organophosphates blue
Choose the correct answer from the options given below:More text goes
here.
Options:-
.1:R, 2:Q, 3: S, 4: T, 5: P , Option ID :- 365,
. 1:P, 2:Q, 3: T, 4: S, 5: R , Option ID :- 366,
. 1:Q, 2:S, 3:P, 4:R, 5: T , Option ID :- 367,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 34 of 48
Response Sheet 02/05/22, 8:48 PM
. 1:T,
2:Q, 3: R, 4:P, 5:S , Option ID :- 368,
Answer Given:- 1:R, 2:Q, 3: S, 4: T, 5: P , Option ID : -365
Question ID:- 87
Match List I with List II Match the following drugs with their classes.
List I List II
Drugs Classes
A. I. IL-2 receptor
Anakinra antagonist
B.
II. TNF! inhibitors
Basiliximab
C. III. Calcineurin
Infliximab inhibitors
D. IV. mTOR
Tacrolimus inhibitors
V. IL-1 receptor
antagonist
Options:-
.A -III , B -II , C -I , D - IV , Option ID :- 345,
. A -V, B -II , C -III, D - I , Option ID :- 346,
. A -I , B -III , C -V , D -II , Option ID :- 347,
. A -V , B -I , C -II , D - III , Option ID :- 348,
Answer Given:- A -I , B -III , C -V , D -II , Option ID : -347
List I List II
A. P. Post marketing
Phase-I surveillance
B.
Q. Microdosing
Phase-0
C.
R. First in human dose
Phase-3
D.
S. Multicentric trials
Phase-4
Options:-
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 35 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 89
Options:-
.Inhibits the side effects of Diphenoxylate , Option ID :- 353,
. Discourage abuse of Diphenoxylate , Option ID :- 354,
. Augment the anti-motility action of Diphenoxylate , Option ID :- 355,
. Suppress gastroenteritis-related vomiting , Option ID :- 356,
Answer Given:- Inhibits the side effects of Diphenoxylate , Option ID :
-353
Question ID:- 91
Options:-
.OECD Guideline 401 , Option ID :- 361,
. OECD Guideline 420 , Option ID :- 362,
. OECD Guideline 423 , Option ID :- 363,
. OECD Guideline 425 , Option ID :- 364,
Answer Given:- OECD Guideline 420 , Option ID : -362
Options:-
.Increased LDL , Option ID :- 413,
. Increased HDL , Option ID :- 414,
. Reduced HDL , Option ID :- 415,
. Increased triglycerides , Option ID :- 416,
Answer Given:- Increased HDL , Option ID : -414
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 36 of 48
Response Sheet 02/05/22, 8:48 PM
Question ID:- 99
Options:-
.A, B and D only , Option ID :- 393,
. A, B and D only , Option ID :- 394,
. C only , Option ID :- 395,
. D only , Option ID :- 396,
Answer Given:- C only , Option ID : -395
Options:-
.Lipoma , Option ID :- 409,
. Adenoma , Option ID :- 410,
. Melanoma , Option ID :- 411,
. Osteoma , Option ID :- 412,
Answer Given:- Osteoma , Option ID : -412
Question ID:- 90
B. in striatum (antiparkinsonian)
C. in CTZ (antiemetic)
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 37 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.A, B and D only , Option ID :- 357,
. A, B and C only , Option ID :- 358,
. B and D only , Option ID :- 359,
. A and B only , Option ID :- 360,
Answer Given:- A, B and D only , Option ID : -357
Question ID:- 88
Match List I with List II Match the following with their mechanism of
action
List I List II
Mechanism of action Drugs
A. DPP4 inhibitors I. Metformin
B. KATP Channel blocker II. Pioglitazone
C. PPARγ activator III. Glimepiride
D. AMPK Activator IV. Teneligliptin
V. !! glucosidase inhibitors
Options:-
.A -II , B -V , C -III , D -IV , Option ID :- 349,
. A - II, B - III, C -IV , D -I , Option ID :- 350,
. A -IV , B -III , C -II , D -I , Option ID :- 351,
. A -IV, B - I, C -V , D -III , Option ID :- 352,
Answer Given:- A - II, B - III, C -IV , D -I , Option ID : -350
Which of the following statements are true with the Adverse Drug
Reactions?
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 38 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.A and B are true while C and D are false. , Option ID :- 445,
. A and C are true while B and D are false. , Option ID :- 446,
. B, C and D are false, Only A is true. , Option ID :- 447,
. A, B and C are false, Only D is true. , Option ID :- 448,
Answer Given:- B, C and D are false, Only A is true. , Option ID : -447
Options:-
.Antigens on RBCs , Option ID :- 433,
. MHCs on WBCs , Option ID :- 434,
. MHCs on RBCs , Option ID :- 435,
. Antigens on WBCs , Option ID :- 436,
Answer Given:- Antigens on RBCs , Option ID : -433
Question ID:- 94
Options:-
.Phenobarbital is a short acting barbiturate and hence safe to induce
sleep in neonates , Option ID :- 373,
. Phenobarbital suppresses the bilirubin synthesis in neonates , Option
ID :- 374,
. Phenobarbital suppresses hepatic glucuronyl transferase and increases
clearance of bilirubin , Option ID :- 375,
. Phenoarbital induces hepatic glucuronyl transferase and increases
clearance of bilirubin , Option ID :- 376,
Answer Given:- Phenobarbital is a short acting barbiturate and hence
safe to induce sleep in neonates , Option ID : -373
Question ID:- 97
A. They get converted into highly nucleophilic anions and bind to the
nitrogen atom of guanine intercalating the DNA strands
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 39 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.A, B and D only are correct , Option ID :- 385,
. Only B is correct , Option ID :- 386,
. Only A and B are correct , Option ID :- 387,
. All A, B, C and D are correct , Option ID :- 388,
Answer Given:- Only B is correct , Option ID : -386
Options:-
.get approval to conduct clinical trials , Option ID :- 453,
. get market approval of new chemical entities , Option ID :- 454,
. get market approval of generics , Option ID :- 455,
. get approval for animal studies of new chemical entities , Option ID :-
456,
Answer Given:- get approval to conduct clinical trials , Option ID : -453
Formation and maintenance of myelin sheath around CNS axons are done
by
Options:-
.Schwann cells , Option ID :- 417,
. Oligodendrocytes , Option ID :- 418,
. Microglia , Option ID :- 419,
. Astrocytes , Option ID :- 420,
Answer Given:- Schwann cells , Option ID : -417
Question ID:- 98
Options:-
.Two isoforms , Option ID :- 389,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 40 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Protects the bone by assisting in fracture repair , Option ID :- 429,
. Has osteogenic cells which enable bone to grow in thickness, but not in
length , Option ID :- 430,
. It is composed of an outer fibrous layer of dense irregular connective
tissue and an inner osteogenic layer that consists of cells , Option ID :-
431,
. All of these , Option ID :- 432,
Answer Given:- All of these , Option ID : -432
At the site of tissue injury, the activated platelet releases ADP and
activates surrounding platelets to form platelet-plug, but this process
will not continue to activate whole platelets in the body to form a
massive ball of platelets because
Options:-
.The adjacent normal endothelial cells physiologically release ‘NO’ which
is a platelet inhibitor , Option ID :- 421,
. There will be plasminogen activators in the plasma , Option ID :- 422,
. There will be plasminogen activator inhibitors in plasma , Option ID :-
423,
. There will be a tissue plasminogen activator (tPA) which inhibits the
platelets , Option ID :- 424,
Answer Given:- There will be plasminogen activators in the plasma ,
Option ID : -422
Options:-
.There will not be any movement of solutes across the RBC membrane ,
Option ID :- 425,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 41 of 48
Response Sheet 02/05/22, 8:48 PM
. The RBC shape and size will not change , Option ID :- 426,
. Because the osmotic pressure across the membrane is same the
solutes will not cross across the RBC membrane , Option ID :- 427,
. All of these , Option ID :- 428,
Answer Given:- All of these , Option ID : -428
Question ID:- 95
Options:-
.Fluoroquinolones , Option ID :- 377,
. Tetracyclines , Option ID :- 378,
. Cephalosporins , Option ID :- 379,
. Aminoglycosides , Option ID :- 380,
Answer Given:- Fluoroquinolones , Option ID : -377
Question ID:- 93
Options:-
.There will be a rise in the blood pressure , Option ID :- 369,
. There will be a fall in the blood pressure , Option ID :- 370,
. The blood pressure will remain unchanged , Option ID :- 371,
. The patient may suffer severe bronchoconstriction , Option ID :- 372,
Answer Given:- There will be a rise in the blood pressure , Option ID :
-369
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 42 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.A, B and C only , Option ID :- 441,
. A, B and D only , Option ID :- 442,
. A, C and D only , Option ID :- 443,
. C only , Option ID :- 444,
Answer Given:- A, C and D only , Option ID : -443
Options:-
.Karyolysis , Option ID :- 401,
. Nuclear clumping , Option ID :- 402,
. Phagocytosis , Option ID :- 403,
. Cytoskeletal damage , Option ID :- 404,
Answer Given:- Phagocytosis , Option ID : -403
Options:-
.The incidence of Adverse Drug Reactions diminishs with advancement
of age. , Option ID :- 437,
. Dose reduction is inevitable for each and every drug used in geriatric
patients. , Option ID :- 438,
. Patient compliance is highest in geriatric patients. , Option ID :- 439,
. Polypharmacy is often a problem in elderly. , Option ID :- 440,
Answer Given:- Dose reduction is inevitable for each and every drug used
in geriatric patients. , Option ID : -438
Question ID:- 96
Options:-
.Bismuth subsalicylate, metronidazole, tetracycline and a proton pump
inhibitor , Option ID :- 381,
. Streptomycin, metronidazole, tetracycline and a proton pump inhibitor
, Option ID :- 382,
. Sulfasalazine, metronidazole, tetracycline and a proton pump inhibitor
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 43 of 48
Response Sheet 02/05/22, 8:48 PM
, Option ID :- 383,
. Bismuth subsalicylate, metronidazole, azithromycin and a proton pump
inhibitor , Option ID :- 384,
Answer Given:- Bismuth subsalicylate, metronidazole, azithromycin and a
proton pump inhibitor , Option ID : -384
Options:-
.Creatine Kinase-MB , Option ID :- 405,
. Aspartate aminotransferase , Option ID :- 406,
. Lactate dehydrogenase , Option ID :- 407,
. Cardiac troponin , Option ID :- 408,
Answer Given:- Cardiac troponin , Option ID : -408
Options:-
.A, B and D only , Option ID :- 397,
. A and B , Option ID :- 398,
. B and C , Option ID :- 399,
. C and D , Option ID :- 400,
Answer Given:- A, B and D only , Option ID : -397
Options:-
.Fractional , Option ID :- 489,
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 44 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Both Statement I and Statement II are correct , Option ID :- 465,
. Both Statement I and Statement II are incorrect , Option ID :- 466,
. Statement I is correct but Statement II is incorrect , Option ID :- 467,
. Statement I is incorrect but Statement II is correct , Option ID :- 468,
Answer Given:- Both Statement I and Statement II are correct , Option
ID : -465
In light of the above statements, choose the correct answer from the
options given below
Options:-
.Both Statement I and Statement II are true , Option ID :- 477,
. Both Statement I and Statement II are false , Option ID :- 478,
. Statement I is true but Statement II is false , Option ID :- 479,
. Statement I is false but Statement II is true , Option ID :- 480,
Answer Given:- Both Statement I and Statement II are true , Option ID :
-477
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 45 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Mumbai , Option ID :- 457,
. Lucknow , Option ID :- 458,
. Kolkata , Option ID :- 459,
. Hyderabad , Option ID :- 460,
Answer Given:- Hyderabad , Option ID : -460
Options:-
.THREE , Option ID :- 461,
. FOUR , Option ID :- 462,
. SIX , Option ID :- 463,
. EIGHT , Option ID :- 464,
Answer Given:- SIX , Option ID : -463
Options:-
.Product life cycle management , Option ID :- 493,
. SWOT analysis , Option ID :- 494,
. Product portfolio management , Option ID :- 495,
. Gap analysis , Option ID :- 496,
Answer Given:- SWOT analysis , Option ID : -494
Crystallizer Principle/Characteristics
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 46 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.A -I , B -II , C -IV , D -III , Option ID :- 481,
. A -III , B -I , C -IV , D -II , Option ID :- 482,
. A -I , B -IV , C -III , D -II , Option ID :- 483,
. A -II , B -III , C -I , D -IV , Option ID :- 484,
Answer Given:- A -I , B -IV , C -III , D -II , Option ID : -483
Options:-
.Both Statement I and Statement II are correct , Option ID :- 485,
. Both Statement I and Statement II are incorrect , Option ID :- 486,
. Statement I is correct but Statement II is incorrect , Option ID :- 487,
. Statement I is incorrect but Statement II is correct , Option ID :- 488,
Answer Given:- Both Statement I and Statement II are correct , Option
ID : -485
Viable cells (viability assay) are assayed by all of the following methods
except
Options:-
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 47 of 48
Response Sheet 02/05/22, 8:48 PM
Options:-
.Insulin , Option ID :- 469,
. Etoposide , Option ID :- 470,
. Lactose , Option ID :- 471,
. Glutethimide , Option ID :- 472,
Answer Given:- Lactose , Option ID : -471
Options:-
.Product positioning , Option ID :- 497,
. Product differentiation , Option ID :- 498,
. Product targeting , Option ID :- 499,
. Market segmentation , Option ID :- 500,
Answer Given:- Product targeting , Option ID : -499
Print ResponseSheet
https://ntagpat2022.cbtexam.in/Candidate/ResponseSheet.aspx?…3cb167-7b04-46ba-b1b7-afad2461e9e2&Rollno=HR03000126&PgId=74 Page 48 of 48